Study of more than 4 million adults finds marijuana use linked to nearly fourfold rise in type 2 diabetes risk
A new, large observational analysis of electronic health records covering more than 4 million adults reports cannabis users had nearly a fourfold higher chance of developing type 2 diabetes over five years versus matched non‑users, prompting calls for updated public‑health guidance.
Key takeaways
- Scale: Real‑world data from 54 health systems across the US and Europe covering over 4 million adults were analyzed.
- Magnitude: Among 96,795 adults aged 18–50 with cannabis‑related diagnoses, 2.2% developed type 2 diabetes in five years versus 0.6% of matched controls — a near fourfold increase.
- Limitations: The study is observational and cannot establish causation; additional research is needed on dose, delivery method, and mechanisms.
- Local impact: Findings could affect health care demand, screening and public‑health messaging in regions with sizable cannabis markets such as the Inland Empire.
Study methods and main findings
Researchers pooled electronic health records from 54 health systems in the United States and Europe to search for links between cannabis‑related diagnoses and subsequent type 2 diabetes. The full dataset covered more than 4 million adults, making this one of the largest real‑world examinations of the marijuana–diabetes association presented at the 2025 Annual Meeting of the European Association for the Study of Diabetes (ScienceDaily, MedicalXpress).
Cohort details and outcomes
Within the cohort, 96,795 adults aged 18–50 had documented cannabis‑related diagnoses. Over a five‑year follow‑up period, 2.2% of those patients developed type 2 diabetes compared with 0.6% of matched controls who had no substance‑use or major chronic conditions (ScienceDaily; MedicalXpress; MedicalNewsToday).
Adjusted risk estimate
After adjusting for known risk factors — including high cholesterol, high blood pressure, existing heart disease, and use of alcohol or cocaine — the association persisted: people with cannabis‑related diagnoses had nearly four times the risk of developing type 2 diabetes compared with matched non‑users, according to the study presentation (ScienceDaily; MedicalXpress).
Possible explanations and limits of the data
The investigators and independent experts caution that correlation does not equal causation. The study shows a strong statistical link in a very large real‑world sample, but it cannot identify which biological or behavioral mechanisms — if any — cause the higher diabetes rates.
“The study is observational and cannot prove cause and effect,” experts noted, urging further research into metabolic effects, appetite changes, weight gain and potential insulin resistance associated with cannabinoids.
Researchers highlighted several hypotheses that warrant study: cannabis‑related insulin resistance, appetite and dietary changes that promote weight gain, and other metabolic effects of cannabinoids. The dataset did not record delivery method or dose, so effects by smoking, vaping or edibles could not be separated (ScienceDaily; MedicalXpress; MedicalNewsToday).
How this fits with earlier research
Previous studies produced mixed results: smaller investigations sometimes found little or no increased diabetes risk after adjusting for confounders, while other research focused on specific patient groups or short‑term outcomes. The present study’s large, diverse real‑world sample makes its association noteworthy, though it does not resolve past inconsistencies (ScienceDaily; MedicalXpress; selected prior reviews).
Expert and organizational views
Clinical commentators urged clinicians to include cannabis use in routine diabetes risk assessments and counseling. Health organizations such as Diabetes Canada have warned that cannabis may harm metabolic health and advised caution for people with or at risk for diabetes.
Commentaries tied to the new study recommended stronger public education as cannabis legalization and use expand in many regions (ScienceDaily; MedicalXpress; MedicalNewsToday; Economic Times).
Implications for the Inland Empire
The study’s findings have several local implications for the Inland Empire (San Bernardino and Riverside counties), where cannabis retail and the related economy have expanded since legalization:
- Economic impact: Increased long‑term diabetes risk among cannabis users could raise demand for diabetes care and screening, potentially increasing costs for clinics, employers and insurers in the region.
- Political consequences: Officials who relied on cannabis tax revenue may face new public‑health questions and decisions about funding prevention and education programs.
- Social effects: Communities with existing diabetes disparities — including low‑income and Spanish‑speaking populations — may be disproportionately affected; targeted, culturally appropriate outreach will be essential.
- Cultural relevance: Many residents use cannabis for recreational or medicinal reasons; clinicians should offer balanced discussions of potential long‑term metabolic risks versus short‑term benefits rather than simple abstinence messaging.
Practical applications for residents
What residents can do:
- Ask your doctor: Tell your primary care provider about cannabis use so clinicians can monitor blood sugar, hemoglobin A1c and other metabolic markers (MedicalXpress; ScienceDaily).
- Monitor diet and activity: If cannabis increases appetite or leads to unhealthy choices, track food intake and maintain physical activity to lower diabetes risk (MedicalNewsToday).
- Consider cutting back: People with family histories of diabetes or other risk factors should discuss reducing or stopping cannabis with health professionals; substance‑use programs could integrate diabetes counseling.
- Stay informed: Watch for evolving guidance from public‑health agencies as further studies clarify risks and mechanisms (ScienceDaily).
